Antioxidant effect of combined administration of metformin and propionate in a rat model of type 2 diabetes mellitusYuliia Osadchu, Larysa Natrus, Yuliia Klys et al.
A computational pipeline for automated disease and drug characterisation in a neurodegenerative modelStefanie Zhang, Edward C Harding, Florian T Merkle
The effect of second-generation antipsychotics on mitochondria and the development of metabolic syndromeKatherine Mortimer, Mohammed Zia Ul Haq Katshu, Reinhard Stöger, Lisa Chakrabarti
The estrogen-immune axis: A key regulator of behavioural inflexibilityMairead Sullivan, Sarita Dam, Angela Maria Ottomana et al.
New insights into the neuroprotective effects of anti-diabetic drugs using a mouse model of prion diseaseDmytro Shepilov, Edward Harding, Galyna Skibo, Florian Merkle
Investigating the therapeutic potential of metformin in ameliorating tau pathology in a cellular model of Alzheimer’s diseaseSrinithya Paruchuri, Shreyasi Chatterjee
Metformin administration mitigates early life stress-induced disruptions in hippocampal neurogenesisEkin Baysal, İrem İnanç, Deniz Billur, Esra Erdemli
Metformin inhibits orofacial neuropathy through p-AMPK/p-mTOR-mediated p-p38 MAPK activation in streptozotocin-induced diabetic neuropathic miceJihee Yeo, Roh Dea-Hyun
Subchronic administration of the antidiabetic drug metformin mitigates cognitive impairments in a mouse model of type 2 diabetes mellitusEdoardo Pisa, Martina Presta, Angela Maria Ottomana, Simone Macrì